183 related articles for article (PubMed ID: 38707900)
1. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
Su Z; Wan Q
Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
[TBL] [Abstract][Full Text] [Related]
2. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
3. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
Wang Y; Wang J; Yan Z; Liu S; Xu W
Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
[TBL] [Abstract][Full Text] [Related]
4. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
[TBL] [Abstract][Full Text] [Related]
6. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
7. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
8. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
[TBL] [Abstract][Full Text] [Related]
9. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
10. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
Zou M; Shao Z
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
[TBL] [Abstract][Full Text] [Related]
11. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study.
Li X; Liang Z
J Cell Mol Med; 2024 Apr; 28(8):e18255. PubMed ID: 38526030
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study.
Wang H; Pang J; Zhou Y; Qi Q; Tang Y; Gul S; Sheng M; Dan J; Tang W
Clin Transl Allergy; 2024 Apr; 14(4):e12350. PubMed ID: 38573314
[TBL] [Abstract][Full Text] [Related]
13. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Marchand LL; Phipps AI; Buchanan DD; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Smith GD; Brennan P; Herzig KH; Jarvelin MR; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
medRxiv; 2023 May; ():. PubMed ID: 37205426
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor mediates the impact of PM
Li M; Shi P; Yang H; Tong S; Qiu N; Yao F; Du Y; Xi S; Wang F
Ecotoxicol Environ Saf; 2024 Jan; 270():115896. PubMed ID: 38184974
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome.
Si S; Liu H; Xu L; Zhan S
Genome Med; 2024 Jun; 16(1):84. PubMed ID: 38898508
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.
Cao M; Cui B
Cardiovasc Diabetol; 2024 Apr; 23(1):126. PubMed ID: 38614964
[TBL] [Abstract][Full Text] [Related]
18. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.
Zhou S; Tao B; Guo Y; Gu J; Li H; Zou C; Tang S; Jiang S; Fu D; Li J
J Transl Med; 2024 Jun; 22(1):557. PubMed ID: 38858729
[TBL] [Abstract][Full Text] [Related]
19. Innovate therapeutic targets for autoimmune diseases: insights from proteome-wide mendelian randomization and Bayesian colocalization.
Jin Q; Ren F; Song P
Autoimmunity; 2024 Dec; 57(1):2330392. PubMed ID: 38515381
[TBL] [Abstract][Full Text] [Related]
20. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.
Wang Q; Shi Q; Wang Z; Lu J; Hou J
BMC Med; 2023 Sep; 21(1):377. PubMed ID: 37775746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
